In addition to its role in chemotherapy and radiotherapy resistance, FOXM1 is involved in reducing autophagic death in glioma cells by regulating the expression of Ubiquitin-conjugating enzyme E2C (UBE2C), which plays a critical role in the development of gliomas. Here, UBE2C is linked to central nervous system cancer.